Abstract
Boron neutron capture therapy (BNCT) is a promising cancer binary therapy modality that utilizes the nuclear capture reaction of thermal neutrons by boron-10 resulting in a localized release of high- and low-linear energy transfer (LET) radiation. Electrochemotherapy (ECT) is based on electroporation (EP) that induces opening of pores in cell membranes, allowing the entry of compounds. Because EP is applied locally to a tumor, the compound is incorporated preferentially by tumor cells. Based on the knowledge that the therapeutic success of BNCT depends centrally on the boron content in tumor and normal tissues and that EP has proven to be an excellent facilitator of tumor biodistribution of an anti-tumor agent, the aim of this study was to evaluate if EP can optimize the delivery of boronated compounds. We performed biodistribution studies and qualitative microdistribution analyses of boron employing the boron compound sodium decahydrodecaborate (GB-10) + EP in the hamster cheek pouch oral cancer model. Syrian hamsters with chemically induced exophytic squamous cell carcinomas were used. A typical EP treatment was applied to each tumor, varying the moment of application with respect to the administration of GB-10 (early or late). The results of this study showed a significant increase in the absolute and relative tumor boron concentration and optimization of the qualitative microdistribution of boron by the use of early EP + GB-10 versus GB-10 without EP. This strategy could be a tool to improve the therapeutic efficacy of BNCT/GB-10 in vivo.
Similar content being viewed by others
References
Achilli C, Jadhav SA, Guidetti GF, Ciana A, Abbonante V, Malara A, Fagnoni M, Torti M, Balduini A, Balduini C, Minetti G (2014) Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets. Chem Biol Drug Des 83(5):532–540. https://doi.org/10.1111/cbdd.12264
Aihara T, Morita N, Kamitani N, Kumada H, Ono K, Hiratsuka J, Harada T (2014) BNCT for advanced or recurrent head and neck cancer. Appl Radiat Isot 88:12–15. https://doi.org/10.1016/j.apradiso.2014.04.007
Barth RF, Soloway AH, Fairchild RG (1990) Boron neutron capture therapy of cancer. Cancer Res 50(4):1061–1070
Barth RF, Coderre JA, Vicente MGH, Blue TE (2005) Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11:3987–4002
Carlsson J, Forssell-Aronsson E, Swedish Glimelius B (2002) Radiation therapy through activation of stable nuclides. Cancer Soc Invest Group 41(7–8):629–634. https://doi.org/10.1080/028418602321028238
Ceberg CP, Brun A, Mir LM, Persson BR, Salford LG (1994) Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo a new possibility in boron neutron capture therapy. Anticancer Drugs 5(4):463–466
Cemažar M, Miklavcic D, Scancar J, Dolzan V, Golouh R, Sersa G (1999) Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 79(9–10):1386–1391. https://doi.org/10.1038/sj.bjc.6690222
Cemažar M, Skrk J, Mitrovic B, Sersa G (2000) Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH. Br J Radiol 73(866):195–200. https://doi.org/10.1259/bjr.73.866.10884734
Cemažar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie J (2008) Electrochemotherapy in veterinary oncology. J Vet Intern Med 22(4):826–831. https://doi.org/10.1111/j.1939-1676.2008.0117.x
Cemažar J, Kotnik T (2012) Dielectrophoretic field-flow fractionation of electroporated cells. Electrophoresis 33(18):2867–2874. https://doi.org/10.1002/elps.201200265
Diaz A, Stelzer K, Laramore G, Wiersema R (2002) Pharmacology studies of Na2 10B10H10 (GB-10) in human tumor patients. In: Sauerwein MW, Moss R, Wittig A (eds) Research and development in neutron capture therapy. Monduzzi Editore International Proceedings Division, Bologna, pp 993–999
Garabalino MA, Heber EM, Monti Hughes A, Pozzi ECC, Molinari AJ, Nigg DW, Bauer W, Trivillin VA, Schwint AE (2014) Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA. Appl Radiat Isot 88:64–68. https://doi.org/10.1016/j.apradiso.2013.11.118
Gehl J, Geertsen PF (2000) Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 10:585–589
Goszczyński TM, Kowalski K, Leśnikowski ZJ, Boratyński J (2015) Solid state, thermal synthesis of site-specific protein-boron cluster conjugates and their physicochemical and biochemical properties. Biochim Biophys Acta 1850(2):411–418. https://doi.org/10.1016/j.bbagen.2014.11.015
Garabalino MA, Monti Hughes A, Molinari AJ, Heber EM, Pozzi ECC, Cardoso JE, Colombo LL, Nievas SI, Nigg DW, Aromando RF, Itoiz ME, Trivillin VA, Schwint AE (2011) Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model. Radiat Environ Biophys 50:199–207. https://doi.org/10.1007/s00411-010-0345-6
Garabalino MA, Heber EM, Monti Hughes A, González SJ, Molinari AJ, Pozzi EC, Nievas S, Itoiz ME, Aromando RF, Nigg DW, Bauer W, Trivillin VA, Schwint AE (2013) Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model. Radiat Environ Biophys 52(3):351–356. https://doi.org/10.1007/s00411-013-0467-8
Heber E, Trivillin V, Nigg D, Kreimann EL, Itoiz ME, Rebagliati RJ, Batistoni D, Schwint AE (2004) Biodistribution of GB-10(Na2 10B10H10) in an experimental model of oral cancer in the hamster cheek pouch. Arch Oral Biol 49:313–324. https://doi.org/10.1016/j.archoralbio.2003.10.003
Heber EM, Trivillin VA, Nigg DW, Itoiz ME, Gonzalez BN, Rebagliati RJ, Batistoni D, Kreimann EL, Schwint AE (2006) Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model. Arch Oral Biol 51:922–929
Heber EM, Kueffer PJ, Lee MW, Hawthorne MF, Garabalino MA, Molinari AJ, Nigg DW, Bauer W et al (2012) Boron delivery with liposomes for boron neutron capture therapy (BNCT): biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential. Radiat Environ Biophys 51(2):195–200. https://doi.org/10.1007/s00411-011-0399-0
Heber EM, Hawthorne MF, Kueffer PJ, Garabalino MA, Thorp SI, Pozzi EC, Monti Hughes A, Maitz CA, Jalisatgi SS, Nigg DW, Curotto P, Trivillin VA, Schwint AE (2014) Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model. Proc Natl Acad Sci USA 111(45):16077–16081. https://doi.org/10.1073/pnas.1410865111
Hopewell JW, Morris GM, Schwint A, Coderre JA (2011) The radiobiological principles of boron neutron capture therapy: a critical review. Appl Radiat Isot 69(12):1756–1759. https://doi.org/10.1016/j.apradiso.2011.04.019
Kang W, Svirskis D, Sarojini V, McGregor AL, Bevitt J, Wu Z (2017) Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: an in vitro boron neutron capture therapy study. Oncotarget 8(22):36614–36627. https://doi.org/10.18632/oncotarget.16625
Kankaanranta L, Seppala T, Koivunoro H, Saarilahti K, Atula T, Collan J, Salli E, Kortesniemi M, Uusi-Simola J, Makitie A, Seppanen M, Minn H, Kotiluoto P, Auterinen I, Savolainen S, Kouri M, Joensuu H (2007) Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J RadiatOncol Biol Phys 69(2):475–482. https://doi.org/10.1016/j.ijrobp.2007.03.039
Kankaanranta L, Seppala T, Koivunoro H, Saarilahti K, Atula T, Collan J, Salli E, Kortesniemi M, Uusi-Simola J, Valimaki P, Makitie A, Seppanen M, Minn H, Revitzer H, Kouri M, Kotiluoto P, Seren T, Auterinen I, Savolainen S, Joensuu H (2012) Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. Int J Radiat Oncol Biol Phys 82(1):e67–e75. https://doi.org/10.1016/j.ijrobp.2010.09.057
Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, Kirihata M, Nakazawa M, Yura Y (2004) Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61(5):1069–1073. https://doi.org/10.1016/j.apradiso.2004.05.059
Kato I, Fujita Y, Ohmae M, Sakrai Y, Kumada H, Murata AI, Miyamaru H, Maruhashi A, Kirihata M, Imahori Y, Suzuki M, Sumi T, Iwai S, Nakazawa M, Ono K (2009) Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies. Appl Radiat Isot 67(7-8Suppl):S37–S42. https://doi.org/10.1016/j.apradiso.2009.03.103
Kimura Y, Ariyoshi Y, Shimahara M, Miyatake S, Kawabata S, Ono K, Suzuki M, Maruhashi A (2009a) Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node. Appl Radiat Isot 67:S47–S49. https://doi.org/10.1016/j.apradiso.2009.03.01
Kimura Y, Ariyoshi Y, Miyatake S, Shimahara M, Kawabata S, Ono K (2009b) Boron neutron capture therapy for papillary cystadenocarcinoma in the upper lip: a case report. Int J Oral Maxillofac Surg 38(3):293–295. https://doi.org/10.1016/j.ijom.2008.12.010
Kreimann EL, Itoiz ME, Dagrosa A, Garavaglia R, Farias S, Batistoni D, Schwint AE (2001a) The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Cancer Res 61(24):8775–8781
Kreimann EL, Itoiz ME, Longhino J, Blaumann H, Calzetta O, Schwint AE (2001b) Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Cancer Res 61:8638–8642
Latella MC, Di Salvo MT, Cocchiarella F, Benati D, Grisendi G, Comitato A, Marigo V, Recchia A (2016) In vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR/Cas 9 in the mouse retina. Mol Ther Nucleic Acids 5(11):e389. https://doi.org/10.1038/mtna.2016.92
Lenzi R, Muscatello L, Saibene AM, Felisati G, Pipolo C (2017) The controversial role of electrochemotherapy in head and neck cancer: a systematic review of the literature. Eur Arch Otorhinolaryngol 274(6):2389–2394. https://doi.org/10.1007/s00405-017-4490-2
Luderer MJ, de la Puente P, Azab AK (2015) Advancements in tumor targeting strategies for boron neutron capture therapy. Pharm Res 32(9):2824–2836. https://doi.org/10.1007/s11095-015-1718-y
Maglietti F, Michinski S, Olaiz N, Castro M, Suárez C, Marshall G (2013a) The role of pH fronts in tissue electroporation based treatments. PLoS One 8(11):e80167. https://doi.org/10.1371/journal.pone.0080167
Maglietti F, Michinski S, Olaiz N, Castro M, Suárez C, Marshall G (2013b) The role of pH fronts in tissue electroporation based treatments. PLoS One 8(11):e80167. https://doi.org/10.1371/journal.pone.0080167
Maglietti F, Tellado M, Olaiz N, Michinski S, Marshall G (2017) Minimally invasive electrochemotherapy procedure for treating nasal duct tumors in dogs using a single needle electrode. Radiol Oncol 51(4):422–430. https://doi.org/10.1515/raon-2017-0043
Marty M, Sersa G, Garbay JR, Gehl J, Collins C, Snoj M, Billard V, Geertsen P, Larkin J, Miklavcic D, Pavlovic I, Paulin-Kosir S, Cemazar M, Morsli N, Soden D, Rudolf Z, Robert C, O’Sullivan G, Mir L (2006) Electrochemotherapy a simple, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures for Electrochemotherapy) study. Eur J Cancer Supp 4:3–13 (Special issue “Electrochemotherapy”)
Mevio N, Bertino G, Occhini A, Scelsi D, Tagliabue M, Mura F, Benazzo M (2012) Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results. Tumori 98(3):308–313. https://doi.org/10.1700/1125.12397
Mir LM (2006) Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl 4:38–44
Miyatake S, Kawabata S, Hiramatsu R, Kuroiwa T, Suzuki M, Kondo N, Ono K (2016) Boron Neutron Capture Therapy for Malignant Brain Tumors. Neurol Med Chir (Tokyo) 56(7):361–371. https://doi.org/10.2176/nmc.ra.2015-0297
Molinari AJ, Pozzi EC, Monti Hughes A, Heber EM, Garabalino MA, Thorp SI, Miller M, Itoiz ME, Aromando RF, Nigg DW, Quintana J, Santa Cruz GA, Trivillin VA, Schwint AE (2011) “Sequential” boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model. Radiat Res 175(4):463–472. https://doi.org/10.1667/RR2148.1
Molinari AJ, Pozzi EC, Monti Hughes A, Heber EM, Garabalino MA, Thorp SI, Miller M, Itoiz ME, Aromando RF, Nigg DW, Trivillin VA, Schwint AE (2012) Tumor blood vessel “normalization” improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer. Radiat Res 177(1):59–68
Molinari AJ, Thorp SI, Portu AM, Saint Martin G, Pozzi EC, Heber EM, Bortolussi S, Itoiz ME, Aromando RF, Monti Hughes A, Garabalino MA, Altieri S, Trivillin VA, Schwint AE (2015) Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels. Acta Oncol 54(1):99–106. https://doi.org/10.3109/0284186X.2014.925140
Monti Hughes A, Heber EM, Pozzi E, Nigg DW, Calzetta O, Blaumann H, Longhino J, Nievas SI, Aromando RF, Itoiz ME, Trivillin VA, Schwint AE (2009) Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT. Appl Radiat Isot 67(7–8 Suppl):S313–S317. https://doi.org/10.1016/j.apradiso.2009.03.070
Monti Hughes A, Pozzi EC, Heber EM, Thorp S, Miller M, Itoiz ME, Aromando RF, Molinari AJ, Garabalino MA, Nigg DW, Trivillin VA, Schwint AE (2011) Boron neutron capture therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval. Oral Oncol 47(11):1017–1022. https://doi.org/10.1016/j.oraloncology.2011.07.014
Monti Hughes AM, Pozzi EC, Thorp S, Garabalino MA, Farias RO, Gonzalez SJ, Heber EM, Itoiz ME, Aromando RF, Molinari AJ, Miller M, Nigg DW, Curotto P, Trivillin VA, Schwint AE (2013) Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model. Oral Dis 19(8):789–795. https://doi.org/10.1111/odi.12077
Monti Hughes A, Longhino J, Boggio E, Medina VA, Martinel Lamas DJ, Garabalino MA, Heber EM, Pozzi ECC, Itoiz ME, Aromando RF, Nigg DW, Trivillin VA, Schwint AE (2017) Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new “B2” configuration of the RA-6 nuclear reactor. Radiat Environ Biophys 56(4):377–387. https://doi.org/10.1007/s00411-017-0710-9
Monti Hughes A, Pozzi E, Thorp SI, Curotto P, Medina VA, Martinel Lamas DJ, Rivera ES, Garabalino MA, Farias RO, Gonzalez SJ, Heber EM, Itoiz ME, Aromando RF, Nigg DW, Trivillin VA, Schwint AE (2015a) Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model. Oral Dis 21(6):770–777. https://doi.org/10.1111/odi.12346
Monti-Hughes A, Aromando RF, Perez MA, Schwint AE, Itoiz AE (2015b) The hamster cheek pouch model for field cancerization studies. Periodontol 2000 67(1):292–311. https://doi.org/10.1111/prd.12066
Moss RL (2014) Critical review, with an optimistic outlook, on boron neutron capture therapy (BNCT). Appl Radiat Isot 88:2–11. https://doi.org/10.1016/j.apradiso.2013.11.109
Nedunchezhian K, Aswath N, Thiruppathy M, Thirugnanamurthy S (2016) Boron neutron capture therapy—a literature review. J Clin Diagn Res 10(12):ZE01–ZE04. https://doi.org/10.7860/JCDR/2016/19890.9024
Niziol J, Zieliński Z, Leś A, Dąbrowska M, Rode W, Ruman T (2014) Synthesis, reactivity and biological activity of N(4)-boronated derivatives of 2′-deoxycytidine. Bioorg Med Chem 22(15):3906–3912. https://doi.org/10.1016/j.bmc.2014.06.014
Olaiz N, Signori E, Maglietti F, Soba A, Suárez C, Turjanski P, Michinski S, Marshall G (2014) Tissue damage modeling in gene electrotransfer: the role of pH. Bioelectrochemistry 100:105–111. https://doi.org/10.1016/j.bioelechem.2014.05.001
Ono K, Kinashi Y, Masunaga S, Suzuki M, Takagaki M (1998) Electroporation increases the effect of borocaptate (10B-BSH) in neutron capture therapy. Int J Radiat Oncol Biol Phys 42(4):823–826
Ono K, Masunaga S, Suzuki M, Kinashi Y, Takagaki M, Akaboshi M (1999) The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice. Int J Radiat Oncol Biol Phys 43(2):431–436
Ono K, Kinashi Y, Suzuki M, Takagaki M, Masunaga S (2000) The combined effect of electroporation and borocaptate in boron neutron capture therapy for murine solid tumors. Jpn J Cancer Res 91:853–858
Orlowski S, Mir LM (1993) Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1154(1):51–63
Pintar M, Langus J, Edhemović I, Brecelj E, Kranjc M, Sersa G, Šuštar T, Rodič T, Miklavčič D, Kotnik T, Kos B (2018) Time-dependent finite element analysis of in vivo electrochemotherapy treatment. Technol Cancer Res Treat. https://doi.org/10.1177/1533033818790510
Portu A, Carpano M, Dagrosa A, Cabrini RL, Saint Martin G (2013) Qualitative autoradiography with polycarbonate foils enables histological and track analyses on the same section. Biotech Histochem 88(5):217–221. https://doi.org/10.3109/10520295.2012.759624
Portu A, Molinari AJ, Thorp SI, Pozzi EC, Curotto P, Schwint AE, Saint Martin G (2015) Neutron autoradiography to study boron compound microdistribution in an oral cancer model. Int J Radiat Biol 91(4):329–335. https://doi.org/10.3109/09553002.2014.995381
Portu A, Garabalino MA, Olaiz N, Itoiz ME, Monti Hughes A, Nigg D, Trivillin V., Marshall G, Schwint AE, Saint Martin G (2017).In: BNCT + electroporation: an autoradiographic analysis. 9th Young Researchers’ BNCT Meeting, Kyoto University, Japan
Pozzi E, Nigg DW, Miller M, Thorp SI, Heber EM, Zarza L, Estryk G, Monti Hughes A, Molinari AJ, Garabalino M, Itoiz ME, Aromando RF, Quintana J, Trivillin VA, Schwint AE (2009) Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer. Appl Radiat Isot 67((7–8 Suppl)):S309–S312. https://doi.org/10.1016/j.apradiso.2009.03.069
Pozzi EC, Cardoso JE, Colombo LL, Thorp S, Monti Hughes A, Molinari AJ, Garabalino MA, Heber EM, Miller M, Itoiz ME, Aromando RF, Nigg DW, Quintana J, Trivillin VA, Schwint AE (2012) Boron neutron capture therapy (BNCT) for liver metastasis: therapeutic efficacy in an experimental model. Radiat Environ Biophys 51(3):331–339. https://doi.org/10.1007/s00411-012-0419-8
Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, Bognel C, Belehradek J Jr, Munck JN, Mir LM (1998) Electrochemotherapy on liver tumours in rabbits. Br J Cancer 77(12):2104–2111
Rao M, Trivillin VA, Heber EM, de Cantarelli M, Itoiz ME, Nigg DW, Rebagliati RJ, Batistoni D, Schwint AE (2004) BNCT of 3 cases of spontaneous head and neck cancer in feline patients. Appl Radiat Isot 61(5):947–952. https://doi.org/10.1016/j.apradiso.2004.05.016
Salford LG, Persson BR, Brun A, Ceberg CP, Kongstad PC, Mir LM (1993) A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 194(2):938–943
Schwint AE, Trivillin VA (2015) ‘Close-to-ideal’ tumor boron targeting for boron neutron capture therapy is possible with ‘less-than-ideal’ boron carriers approved for use in humans. Ther Deliv 6(3):269–272. https://doi.org/10.4155/tde.14.108
Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D, Rudolf Z (1998) Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer 34(8):1213–1218
Sersa G, Cemazar M, Miklavcic D, Chaplin DJ (1999) Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 19(5B):4017–4022
Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z (2000) Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 6(3):863–867
Suzuki M, Kato I, Aihara T, Hiratsuka J, Yoshimura K, Niimi M, Kimura Y, Ariyoshi Y, Haginomori S, Sakurai Y, Kinashi Y, Masunaga S, Fukushima M, Ono K, Maruhashi A (2014) Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. J Radiat Res 55(1):146–153. https://doi.org/10.1093/jrr/rrt098
Trivillin VA, Heber EM, Itoiz ME, Nigg D, Calzetta O, Blaumann H, Longhino J, Schwint AE (2004) Radiobiology of BNCT mediated by GB-10 and GB-10 + BPA in experimental oral cancer. Appl Radiat Isot 61:939–945. https://doi.org/10.1016/j.apradiso.2004.05.015
Trivillin VA, Heber EM, Nigg DW, Itoiz ME, Calzetta O, Blaumann H, Longhino J, Schwint AE (2006) Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically nonselective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Radiat Res 166(2):387–396. https://doi.org/10.1667/RR3592.1
Trivillin VA, Heber EM, Rao M, Cantarelli MA, Itoiz ME, Nigg DW, Calzetta O, Blaumann H, Longhino J, Schwint AE (2008) Boron neutron capture therapy (BNCT) for the treatment of 246 spontaneous nasal planum squamous cell carcinoma in felines. Radiat Environ Biophys 47(1):147–155. https://doi.org/10.1007/s00411-007-0138-8
Trivillin A, Garabalino MA, Colombo LL, Gonzalez SJ, Farías RO, Monti Hughes A, Pozzi ECC, Bortolussi S, Altieri S, Itoiz ME, Aromando RF, Nigg DW, Schwint AE (2014) Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases. Appl Radiat Isot 88:94–98. https://doi.org/10.1016/j.apradiso.2013.11.115
Wang LW, Wang SJ, Chu PY, Ho CY, Jiang SH, Liu YW, Liu YH, Liu HM, Peir JJ, Chou FI, Yen SH, Lee YL, Chang CW, Liu CS, Chen YW, Ono K (2011) BNCT for locally recurrent head and neck cancer: preliminary clinical experience from a phase I/II trial at Tsing Hua open-pool reactor. Appl Radiat Isot 69(12):1803–1806. https://doi.org/10.1016/j.apradiso.2011.03.008
Wang LW, Chen YW, Ho CY, Hsueh Liu YW, Chou FI, Liu YH, Liu HM, Peir JJ, Jiang SH, Chang CW, Liu CS, Lin KH, Wang SJ, Chu PY, Lo WL, Kao SY, Yen SH (2016) Fractionated boron neutron capture therapy in locally recurrent head and neck cancer: a prospective phase I/II trial. Int J Radiat Oncol Biol Phys 95(1):396–403. https://doi.org/10.1016/j.ijrobp.2016.02.028
Wittig A, Collette L, Appelman K, Buhrmann S, Jackel MC, Jockel KH, Schmid KW, Ortmann U, Moss R, Sauerwein WA (2009) EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial. J Cell Mol Med 13(8B):1653–1665. https://doi.org/10.1111/j.1582-4934.2009.00856.x
Xiong H, Qi Y, Zhang Z, Zhou D, Jing X, Huang Y (2015) Borane-conjugated poly (ester-carbonate) amphiphilic block copolymers as potential agents for boron neutron capture therapy. J Control Release 213:e39–e40
National Institute for Health and Care Excellence Interventional Procedures Programme (NICE) (2012) Interventional procedure overview of electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma
Funding
This study was partially funded by Comisión Nacional de Energía Atómica and Instituto Nacional del Cáncer, Argentina.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Garabalino, M.A., Olaiz, N., Portu, A. et al. Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model. Radiat Environ Biophys 58, 455–467 (2019). https://doi.org/10.1007/s00411-019-00796-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00411-019-00796-z